Clinical impact of minimal residual disease in blood and bone marrow of children with acute myeloid leukemia

被引:6
作者
Karol, Seth E. [1 ]
Coustan-Smith, Elaine [2 ]
Pounds, Stanley [3 ]
Wang, Lei [3 ]
Inaba, Hiroto [1 ]
Ribeiro, Raul C. [1 ]
Pui, Ching-Hon [1 ]
Klco, Jeffery M. [4 ]
Rubnitz, Jeffrey E. [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA
[2] Natl Univ Hlth Syst, Dept Pediat, Singapore, Singapore
[3] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA
[4] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN USA
基金
美国国家卫生研究院;
关键词
FLOW-CYTOMETRY; THERAPY; CLEARANCE; MRD;
D O I
10.1182/bloodadvances.2022009534
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The prognostic significance of bone marrow minimal residual disease (MRD) in pediatric patients with acute myeloid leukemia (AML) is well characterized, but the impact of blood MRD is not known. We, therefore, used flow cytometric assessment of leukemia-specific immunophenotypes to measure levels of MRD in both the blood and bone marrow of patients treated in the AML08 (NCT00703820) clinical trial. Blood samples were obtained on days 8 and 22 of therapy, whereas bone marrow samples were obtained on day 22. Among patients who tested as having MRD-negative bone marrow on day 22, neither day-8 nor day-22 blood MRD was significantly associated with the outcome. However, day-8 blood MRD was highly predictive of the outcome among patients who tested as having MRD-positive bone marrow on day 22. Although the measurement of blood MRD on day 8 cannot be used to identify patients who have day-22 MRD-negative bone marrow who are likely to relapse, our findings suggest that day-8 blood MRD results can identify patients with MRD-positive bone marrow who have a dismal prognosis and may be candidates for the early use of experimental therapy.
引用
收藏
页码:3651 / 3657
页数:7
相关论文
共 27 条
[1]   Association Between Anesthesia Exposure and Neurocognitive and Neuroimaging Outcomes in Long-term Survivors of Childhood Acute Lymphoblastic Leukemia [J].
Banerjee, Pia ;
Rossi, Michael G. ;
Anghelescu, Doralina L. ;
Liu, Wei ;
Breazeale, Ashley M. ;
Reddick, Wilburn E. ;
Glass, John O. ;
Phillips, Nicholas S. ;
Jacola, Lisa M. ;
Sabin, Noah D. ;
Inaba, Hiroto ;
Srivastava, Deokumar ;
Robison, Leslie L. ;
Pui, Ching-Hon ;
Hudson, Melissa M. ;
Krull, Kevin R. .
JAMA ONCOLOGY, 2019, 5 (10) :1456-1463
[2]   Morphologic remission status is limited compared to DN flow cytometry: a Children's Oncology Group AAML0531 report [J].
Brodersen, Lisa Eidenschink ;
Gerbing, Robert B. ;
Pardo, M. Laura ;
Alonzo, Todd A. ;
Paine, Dana ;
Fritschle, Wayne ;
Hsu, Fan-Chi ;
Pollard, Jessica A. ;
Aplenc, Richard ;
Kahwash, Samir B. ;
Hirsch, Betsy ;
Ramondi, Susana ;
Wells, Denise ;
Kolb, E. Anders ;
Gamis, Alan S. ;
Meshinchi, Soheil ;
Loken, Michael R. .
BLOOD ADVANCES, 2020, 4 (20) :5050-5061
[3]   Universal monitoring of minimal residual disease in acute myeloid leukemia [J].
Coustan-Smith, Elaine ;
Song, Guangchun ;
Shurtleff, Sheila ;
Yeoh, Allen Eng-Juh ;
Chng, Wee Joo ;
Chen, Siew Peng ;
Rubnitz, Jeffrey E. ;
Pui, Ching-Hon ;
Downing, James R. ;
Campana, Dario .
JCI INSIGHT, 2018, 3 (09)
[4]   Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remission [J].
Diaz-Beya, Marina ;
Labopin, Myriam ;
Maertens, Johan ;
Alijurf, Mahmoud ;
Passweg, Jakob ;
Dietrich, Beelen ;
Schouten, Harry ;
Socie, Gerard ;
Schaap, Nicolaas ;
Schwerdtfeger, Rainer ;
Volin, Liisa ;
Michallet, Mauricette ;
Polge, Emmanuelle ;
Sierra, Jorge ;
Mohty, Mohamad ;
Esteve, Jordi ;
Nagler, Arnon .
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (05) :920-925
[5]   The genomic landscape of core-binding factor acute myeloid leukemias [J].
Faber, Zachary J. ;
Chen, Xiang ;
Gedman, Amanda Larson ;
Boggs, Kristy ;
Cheng, Jinjun ;
Ma, Jing ;
Radtke, Ina ;
Chao, Jyh-Rong ;
Walsh, Michael P. ;
Song, Guangchun ;
Andersson, Anna K. ;
Dang, Jinjun ;
Dong, Li ;
Liu, Yu ;
Huether, Robert ;
Call, Zhongling ;
Mulder, Heather ;
Wu, Gang ;
Edmonson, Michael ;
Rusch, Michael ;
Qu, Chunxu ;
Li, Yongjin ;
Vadodaria, Bhavin ;
Wang, Jianmin ;
Hedlund, Erin ;
Cao, Xueyuan ;
Yergeau, Donald ;
Nakitandwe, Joy ;
Pounds, Stanley B. ;
Shurtleff, Sheila ;
Fulton, Robert S. ;
Fulton, Lucinda L. ;
Easton, John ;
Parganas, Evan ;
Pui, Ching-Hon ;
Rubnitz, Jeffrey E. ;
Dingo, Li ;
Mardis, Elaine R. ;
Wilson, Richard K. ;
Gruber, Tanja A. ;
Mullighan, Charles G. ;
Schlenk, Richard F. ;
Paschka, Peter ;
Doehner, Konstanze ;
Doehner, Hartmut ;
Bullinger, Lars ;
Zhang, Jinghui ;
Klco, Jeffery M. ;
Downing, James R. .
NATURE GENETICS, 2016, 48 (12) :1551-1556
[6]   Early peripheral clearance of leukemia-associated immunophenotypes in AML: centralized analysis of a randomized trial [J].
Gianfaldoni, Giacomo ;
Mannelli, Francesco ;
Intermesoli, Tamara ;
Bencini, Sara ;
Giupponi, Damiano ;
Farina, Giorgio ;
Cutini, Ilaria ;
Bonetti, Maria Ida ;
Masciulli, Arianna ;
Audisio, Ernesta ;
Ferrero, Dario ;
Pavoni, Chiara ;
Scattolin, Anna Maria ;
Bosi, Alberto ;
Rambaldi, Alessandro ;
Bassan, Renato .
BLOOD ADVANCES, 2020, 4 (02) :301-311
[7]   An Inv(16)(p13.3q24.3)-Encoded CBFA2T3-GLIS2 Fusion Protein Defines an Aggressive Subtype of Pediatric Acute Megakaryoblastic Leukemia [J].
Gruber, Tanja A. ;
Gedman, Amanda Larson ;
Zhang, Jinghui ;
Koss, Cary S. ;
Marada, Suresh ;
Ta, Huy Q. ;
Chen, Shann-Ching ;
Su, Xiaoping ;
Ogden, Stacey K. ;
Dang, Jinjun ;
Wu, Gang ;
Gupta, Vedant ;
Andersson, Anna K. ;
Pounds, Stanley ;
Shi, Lei ;
Easton, John ;
Barbato, Michael I. ;
Mulder, Heather L. ;
Manne, Jayanthi ;
Wang, Jianmin ;
Rusch, Michael ;
Ranade, Swati ;
Ganti, Ramapriya ;
Parker, Matthew ;
Ma, Jing ;
Radtke, Ina ;
Ding, Li ;
Cazzaniga, Giovanni ;
Biondi, Andrea ;
Kornblau, Steven M. ;
Ravandi, Farhad ;
Kantarjian, Hagop ;
Ninner, Stephen D. ;
Doehner, Konstanze ;
Doehner, Hartmut ;
Ley, Timothy J. ;
Ballerini, Paola ;
Shurtleff, Sheila ;
Tomizawa, Daisuke ;
Adachi, Souichi ;
Hayashi, Yasuhide ;
Tawa, Akio ;
Shih, Lee-Yung ;
Liang, Der-Cherng ;
Rubnitz, Jeffrey E. ;
Pui, Ching-Hon ;
Mardis, Elaine R. ;
Wilson, Richard K. ;
Downing, James R. .
CANCER CELL, 2012, 22 (05) :683-697
[8]   The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML [J].
Heikamp, Emily B. ;
Henrich, Jill A. ;
Perner, Florian ;
Wong, Eric M. ;
Hatton, Charles ;
Wen, Yanhe ;
Barwe, Sonali P. ;
Gopalakrishnapillai, Anilkumar ;
Xu, Haiming ;
Uckelmann, Hannah J. ;
Takao, Sumiko ;
Kazansky, Yaniv ;
Pikman, Yana ;
McGeehan, Gerard M. ;
Kolb, Edward A. ;
Kentsis, Alex ;
Armstrong, Scott A. .
BLOOD, 2022, 139 (06) :894-906
[9]   2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party [J].
Heuser, Michael ;
Freeman, Sylvie D. ;
Ossenkoppele, Gert J. ;
Buccisano, Francesco ;
Hourigan, Christopher S. ;
Ngai, Lok Lam ;
Tettero, Jesse M. ;
Bachas, Costa ;
Baer, Constance ;
Bene, Marie-Christine ;
Bucklein, Veit ;
Czyz, Anna ;
Denys, Barbara ;
Dillon, Richard ;
Feuring-Buske, Michaela ;
Guzman, Monica L. ;
Haferlach, Torsten ;
Han, Lina ;
Herzig, Julia K. ;
Jorgensen, Jeffrey L. ;
Kern, Wolfgang ;
Konopleva, Marina Y. ;
Lacombe, Francis ;
Libura, Marta ;
Majchrzak, Agata ;
Maurillo, Luca ;
Ofran, Yishai ;
Philippe, Jan ;
Plesa, Adriana ;
Preudhomme, Claude ;
Ravandi, Farhad ;
Roumier, Christophe ;
Subklewe, Marion ;
Thol, Felicitas ;
van de Loosdrecht, Arjan A. ;
van der Reijden, Bert A. ;
Venditti, Adriano ;
Wierzbowska, Agnieszka ;
Valk, Peter J. M. ;
Wood, Brent L. ;
Walter, Roland B. ;
Thiede, Christian ;
Dohner, Konstanze ;
Roboz, Gail J. ;
Cloos, Jacqueline .
BLOOD, 2021, 138 (26) :2753-2767
[10]   Whole transcriptome sequencing reveals a KMT2A-USP2 fusion in infant acute myeloid leukemia [J].
Ikeda, Junji ;
Shiba, Norio ;
Tsujimoto, Shin-ichi ;
Yoshida, Masanori ;
Nakabayashi, Kazuhiko ;
Ogata-Kawata, Hiroko ;
Okamura, Kohji ;
Takeuchi, Masanobu ;
Osumi, Tomoo ;
Tomizawa, Daisuke ;
Hata, Kenichiro ;
Kiyokawa, Nobutaka ;
Ito, Shuichi ;
Kato, Motohiro .
GENES CHROMOSOMES & CANCER, 2019, 58 (09) :669-672